• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于集合的高通量虚拟筛选天然配体,使用 Super Natural-II 数据库针对. 中的细胞壁蛋白 dTDP-4-脱水-rhamnose 还原酶 (RmlD)。

Ensemble-based high-throughput virtual screening of natural ligands using the Super Natural-II database against cell-wall protein dTDP-4-dehydrorhamnose reductase (RmlD) in .

机构信息

DiSTABiF, Università degli Studi della Campania "Luigi Vanvitelli", Caserta, Italy.

School of Chemical and Biotechnology, SASTRA University, Thanjavur, India.

出版信息

J Biomol Struct Dyn. 2022 Jul;40(11):5069-5078. doi: 10.1080/07391102.2020.1867641. Epub 2020 Dec 31.

DOI:10.1080/07391102.2020.1867641
PMID:33382017
Abstract

The disease Tuberculosis (TB) is caused by a bacterium called (). The bacterial cell-wall consists of peptidoglycan layer maintains the cellular integrity and cell viability. The main problem resides in the cell cycle of in its quiescent form which is not targeted by any drugs hence there is an immediate need for new antibiotics to target the cell wall. The current study deals with the dTDP-4-dehydrorahmnose reductase (RmlD) which is the final enzyme in the series of cell-wall proteins of . The RmlD is a part of Carbohydrate biosynthesis has been considered as a good drug target for the novel class of antibiotics. Our study begins with the protein structure prediction, Homology studies were conducted using the Phyre2 web server. The structure is then refined and subjected to molecular dynamics simulations for 50 ns using GROMACS. The clustering analysis has been carried out and generated 41 clusters with 2 Å as the cut-off. Blind docking virtual screening was performed against RmlD protein using the Super Natural-II database with AutoDock4.0. its results helped to screen top ligands based on best binding energies. In both dockings, there are some common residues in which the ligands are interacting and forming the Hydrogen bonds such as Asp-105, Val-158, Thr-160, Gly-161, Arg-224, Arg-256. The ligand-567 giving the best results by being in the top-3 of all the clusters in both blind docking as well as the active-site docking. Hence ligand-567 can be a potential inhibitor of RmlD which can further inhibit the cell-wall synthesis of Communicated by Ramaswamy H. Sarma.

摘要

结核病(TB)是由一种叫做 ()的细菌引起的。细菌细胞壁由肽聚糖层组成,维持细胞的完整性和细胞活力。主要问题在于处于静止状态的 ()的细胞周期,目前没有任何药物可以靶向该周期,因此急需新的抗生素来靶向细胞壁。本研究涉及 dTDP-4-脱水赖氨醇还原酶(RmlD),它是细胞壁蛋白系列中的最后一种酶。RmlD 是碳水化合物生物合成的一部分,已被认为是新型抗生素的一个很好的药物靶点。我们的研究始于蛋白质结构预测,使用 Phyre2 网络服务器进行同源性研究。然后对结构进行细化,并使用 GROMACS 进行 50ns 的分子动力学模拟。进行了聚类分析,并生成了 41 个簇,以 2Å 为截止值。使用 AutoDock4.0 对 RmlD 蛋白进行盲法对接虚拟筛选,使用 SuperNatural-II 数据库。其结果有助于根据最佳结合能筛选出顶级配体。在两种对接中,有一些共同的残基,配体在这些残基中相互作用并形成氢键,如 Asp-105、Val-158、Thr-160、Gly-161、Arg-224、Arg-256。配体-567 在盲法对接和活性位点对接中都在所有簇的前 3 名中给出了最佳结果。因此,配体-567 可能是 RmlD 的潜在抑制剂,它可以进一步抑制细胞壁的合成。

相似文献

1
Ensemble-based high-throughput virtual screening of natural ligands using the Super Natural-II database against cell-wall protein dTDP-4-dehydrorhamnose reductase (RmlD) in .基于集合的高通量虚拟筛选天然配体,使用 Super Natural-II 数据库针对. 中的细胞壁蛋白 dTDP-4-脱水-rhamnose 还原酶 (RmlD)。
J Biomol Struct Dyn. 2022 Jul;40(11):5069-5078. doi: 10.1080/07391102.2020.1867641. Epub 2020 Dec 31.
2
Structure prediction, molecular simulations of RmlD from Mycobacterium tuberculosis, and interaction studies of Rhodanine derivatives for anti-tuberculosis activity.结核分枝杆菌 RmlD 的结构预测、分子模拟及 Rhodanine 衍生物的抗结核活性相互作用研究。
J Mol Model. 2021 Feb 6;27(3):75. doi: 10.1007/s00894-021-04696-2.
3
Identification of potential inhibitors of InhA: a pharmacoinformatics approach.鉴定 InhA 的潜在抑制剂:一种基于药物信息学的方法。
J Biomol Struct Dyn. 2024 Sep;42(15):7957-7971. doi: 10.1080/07391102.2023.2242499. Epub 2023 Aug 1.
4
Novel inhibitors of Mycobacterium tuberculosis dTDP-6-deoxy-L-lyxo-4-hexulose reductase (RmlD) identified by virtual screening.通过虚拟筛选鉴定出结核分枝杆菌 dTDP-6-脱氧-L-塔罗糖-4-己酮糖还原酶(RmlD)的新型抑制剂。
Bioorg Med Chem Lett. 2011 Dec 1;21(23):7064-7. doi: 10.1016/j.bmcl.2011.09.094. Epub 2011 Sep 29.
5
Virtual screening to identify novel potential inhibitors for Glutamine synthetase of .通过虚拟筛选鉴定[具体对象]谷氨酰胺合成酶的新型潜在抑制剂。
J Biomol Struct Dyn. 2020 Oct;38(17):5062-5080. doi: 10.1080/07391102.2019.1695670. Epub 2019 Dec 6.
6
Drug targeted virtual screening and molecular dynamics of LipU protein of Mycobacterium tuberculosis and Mycobacterium leprae.结核分枝杆菌和麻风分枝杆菌 LipU 蛋白的药物靶向虚拟筛选及分子动力学研究。
J Biomol Struct Dyn. 2019 Mar;37(5):1254-1269. doi: 10.1080/07391102.2018.1454852. Epub 2018 Mar 30.
7
Structure based virtual screening and discovery of novel inhibitors against FabD protein of .基于结构的虚拟筛选和新型 FabD 蛋白抑制剂的发现。
J Biomol Struct Dyn. 2024 Aug;42(12):6280-6291. doi: 10.1080/07391102.2023.2233622. Epub 2023 Jul 9.
8
Drug targeting Mycobacterium tuberculosis cell wall synthesis: genetics of dTDP-rhamnose synthetic enzymes and development of a microtiter plate-based screen for inhibitors of conversion of dTDP-glucose to dTDP-rhamnose.靶向结核分枝杆菌细胞壁合成的药物:dTDP-鼠李糖合成酶的遗传学及基于微孔板的dTDP-葡萄糖转化为dTDP-鼠李糖抑制剂筛选方法的开发
Antimicrob Agents Chemother. 2001 May;45(5):1407-16. doi: 10.1128/AAC.45.5.1407-1416.2001.
9
Identification of novel multitarget antitubercular inhibitors against mycobacterial peptidoglycan biosynthetic Mur enzymes by structure-based virtual screening.基于结构的虚拟筛选鉴定新型抗结核分枝杆菌肽聚糖生物合成 Mur 酶的多靶位抑制剂。
J Biomol Struct Dyn. 2022 Nov;40(18):8185-8196. doi: 10.1080/07391102.2021.1908913. Epub 2021 Apr 7.
10
Identification of peptidomimetic compounds as potential inhibitors against MurA enzyme of .鉴定肽模拟化合物作为. MurA 酶潜在抑制剂
J Biomol Struct Dyn. 2020 Oct;38(17):4997-5013. doi: 10.1080/07391102.2019.1696231. Epub 2019 Dec 4.

引用本文的文献

1
The Structural and Molecular Mechanisms of Translational Elongation Factor Proteins.翻译:翻译延伸因子蛋白的结构和分子机制。
Molecules. 2024 Apr 29;29(9):2058. doi: 10.3390/molecules29092058.
2
Anti-tuberculosis drug development targeting the cell envelope of .针对……细胞包膜的抗结核药物研发
Front Microbiol. 2022 Dec 21;13:1056608. doi: 10.3389/fmicb.2022.1056608. eCollection 2022.
3
Drug Discovery for Using Structure-Based Computer-Aided Drug Design Approach.基于结构的计算机辅助药物设计方法在药物发现中的应用。
Int J Mol Sci. 2021 Dec 9;22(24):13259. doi: 10.3390/ijms222413259.
4
Structure-based approaches for drug discovery against .针对……的基于结构的药物发现方法
Comput Struct Biotechnol J. 2021 Jun 24;19:3708-3719. doi: 10.1016/j.csbj.2021.06.034. eCollection 2021.